Showing results (151-160 of 162) with videos related to

Sort By:
Pageof 17
Clinical Journal of the American Society of Nephrology : CJASN|August 24, 2023
Rare Variants in Complement Gene in C3 Glomerulopathy and Immunoglobulin-Mediated Membranoproliferative GNMarie Sophie Meuleman, Paula Vieira-Martins, Carine El Sissy, et al.
Molecular Cancer Therapeutics|December 10, 2009
BMS-754807, a small molecule inhibitor of insulin-like growth factor-1R/IRJoan M Carboni, Mark Wittman, Zheng Yang, et al.
Research Square|June 29, 2026
Precision RNAi for Fibrodysplasia Ossificans Progressiva: a combinatorial, unimolecular, allele selective approachJaeHyuck Shim, Yeon-Suk Yang, Katherine Gross, et al.
Bioorganic & Medicinal Chemistry Letters|March 23, 2005
Design, synthesis, and structure-activity relationships of tetrahydroquinoline-based farnesyltransferase inhibitorsLouis J Lombardo, Amy Camuso, John Clark, et al.
Bioorganic & Medicinal Chemistry Letters|May 15, 2021
Development of BET inhibitors as potential treatments for cancer: A search for structural diversityMatthew D Hill, Haiquan Fang, John Tokarski, et al.
Bioorganic & Medicinal Chemistry Letters|September 24, 2021
Development of BET inhibitors as potential treatments for cancer: A new carboline chemotypeMatthew D Hill, Claude Quesnelle, John Tokarski, et al.
Haematologica|January 8, 2026
Ethnicity affects relapse-free survival in immune-mediated thrombotic thrombocytopenic purpuraJúlia Weisinger, Florian Blanchard, Benoit Suzon, et al.
ACS Medicinal Chemistry Letters|July 21, 2022
Development of BET Inhibitors as Potential Treatments for Cancer: Optimization of Pharmacokinetic PropertiesMatthew D Hill, Haiquan Fang, Derek Norris, et al.
Pediatric Nephrology (Berlin, Germany)|October 24, 2017
Clinical and genetic heterogeneity in familial steroid-sensitive nephrotic syndromeGuillaume Dorval, Olivier Gribouval, Vanesa Martinez-Barquero, et al.
Pageof 17